STEMI: Considerations for Left Main Culprit Lesions.

Left main coronary disease Midwest STEMI Consortium Primary PCI: primary percutaneous coronary revascularization STEMI: ST elevation myocardial infarction

Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
06 2022
Historique:
accepted: 08 03 2022
pubmed: 7 4 2022
medline: 15 6 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

There is a paucity of data regarding the prevalence, clinical characteristics, and outcomes of patients presenting with ST elevation myocardial infarction (STEMI) due to left main (LM) culprit vessel. LM culprit STEMI (LMCSTEMI) is an uncommon, but frequently catastrophic event. Prior meta-analyses and registries have described a varying prevalence of LMCSTEMI, associated cardiogenic shock, and in-hospital mortality among those surviving to hospital presentation. These observed clinical discrepancies may be partially attributable to diverse clinical and angiographical subsets among this STEMI population. STEMI due to LM culprit artery disease represents a clinically high-risk subset of patients with substantial in-hospital mortality. In this paper, we summarize the available clinical data pertaining to STEMI with LM culprit, discuss unique ECG characteristics, and discuss contemporary revascularization therapy. We also report the preliminary findings from a contemporary, STEMI database describing clinical characteristics and angiographically defined subsets of LM culprit STEMI.

Identifiants

pubmed: 35384548
doi: 10.1007/s11886-022-01685-6
pii: 10.1007/s11886-022-01685-6
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-651

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Ameera Ahmed (A)

Cardiovascular Institute of Northern Colorado, Banner Health, Loveland, USA.

Frank V Aguirre (FV)

Prairie Education and Research Cooperative, Springfield, IL, USA.

Jenny Chambers (J)

Prairie Education and Research Cooperative, Springfield, IL, USA.

Scott W Sharkey (SW)

Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, USA.

Mark A Tannenbaum (MA)

Iowa Heart Center, West Des Moines, USA.

Mehmet Yildiz (M)

The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, OH, USA.

Ross Garberich (R)

Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, USA.

Santiago Garcia (S)

Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, USA.

Timothy D Henry (TD)

The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, OH, USA. Tim.Henry@thechristhospital.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH